特布他林联合糖皮质激素治疗慢阻肺急性加重期临床效果分析

打开文本图片集

【摘要】目的：探讨慢阻肺急性加重期（AECOPD）采取特布他林联合糖皮质激素治疗的临床效果。方法：选择我院2020年1月—2023年1月收治的AECOPD患者80例研究，双色球法分为两组，包括对照组（糖皮质激素治疗）与观察组（糖皮质激素+特布他林治疗），每组40例。对比效果。结果：观察组总有效率更高，而症状缓解时间更短，与对照组差异有统计学意义（P0.05），治疗后观察组肺功能指标FVC、FEV1、FEV1/FVC更高，炎症因子IL-6、CRP、TNF-α更低，与对照组差异均有统计学意义（P

【关键词】慢阻肺急性加重期；特布他林；糖皮质激素

Clinical analysis of terbutaline combined with glucocorticoid in the treatment of acute exacerbation of chronic obstructive pulmonary disease

SHEN Sisi， FANG Yan

Traditional Chinese Medicine Hospital in Donghai County， Lianyungang， Jiangsu 222300， China

【Abstract】Objective： To investigate the clinical effect of terbutaline combined with glucocorticoid in the treatment of acute exacerbation of chronic obstructive pulmonary disease （AECOPD）. Methods： 80 cases of AECOPD patients admitted to our hospital from January 2020 to January 2023 were selected for study. They were divided into two groups by double color ball method， including the control group （glucocorticoid treatment） and the observation group （glucocorticoid+terbutaline treatment）， with 40 cases in each group. Comparison effect. Results： The total effective rate of the observation group was higher， and the symptom relief time was shorter， with a statistically significant difference compared to the control group（P0.05）. After treatment， the observation group had higher lung function indicators such as FVC， FEV1， and FEV1/FVC， as well as inflammatory factors such as IL-6， CRP， and TNF- α Lower， with statistically significant differences compared to the control group （P

【Key Words】 Acute exacerbation of chronic obstructive pulmonary disease； Terbutaline； Glucocorticoids

慢性阻塞性肺疾病（简称慢阻肺，COPD）是常见呼吸系统疾病，好发于老年群体，在我国有较高发病率与致死率。（剩余3874字）